Glenmede Trust CO Na Halozyme Therapeutics, Inc. Transaction History

Glenmede Trust CO Na

$18.2 Billion
Q1 2025

A detailed history of Glenmede Trust CO Na transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 499,029 shares of HALO stock, worth $32.1 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

499,029

Previous 483,952 3.12%

Holding current value

$32.1 Million

Previous $23.1 Million 37.63%

% of portfolio

0.18%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$47.74 - $65.16 $719,775 - $982,417	15,077 Added 3.12%	499,029 $31.8 Million
Q4 2024 Feb 14, 2025	SELL	$42.57 - $61.09 $135,330 - $194,205	-3,179 Reduced 0.65%	483,952 $23.1 Million
Q3 2024 Nov 13, 2024	BUY	$51.3 - $64.42 $5.61 Million - $7.04 Million	109,283 Added 28.92%	487,131 $27.9 Million
Q2 2024 Aug 14, 2024	BUY	$37.81 - $52.4 $214,836 - $297,736	5,682 Added 1.53%	377,848 $19.8 Million
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $1.26 Million - $1.57 Million	37,447 Added 11.19%	372,166 $15.1 Million
Q4 2023 Feb 13, 2024	SELL	$33.32 - $42.1 $282,187 - $356,544	-8,469 Reduced 2.47%	334,719 $12.4 Million
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $119,151 - $143,890	-3,268 Reduced 0.94%	343,188 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $19,954 - $25,529	659 Added 0.19%	346,456 $12.5 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $118,197 - $200,352	3,597 Added 1.05%	345,797 $13.2 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $1.7 Million - $2.52 Million	-42,399 Reduced 11.02%	342,200 $19.5 Million
Q3 2022 Nov 16, 2022	SELL	$38.53 - $51.78 $1.79 Million - $2.41 Million	-46,586 Reduced 10.8%	384,599 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $1.76 Million - $2.28 Million	-47,243 Reduced 9.87%	431,185 $19 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $15.3 Million - $19.6 Million	478,428 New	478,428 $19.1 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $6,220 - $10,512	-241 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $2,368 - $2,725	92 Added 61.74%	241 $6,000
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $2,421 - $3,994	149 New	149 $3,000
Q4 2019 Feb 12, 2020	SELL	$14.93 - $19.53 $2,986 - $3,906	-200 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $4,985 - $6,978	-374 Reduced 65.16%	200 $2,000
Q2 2018 Aug 15, 2018	SELL	$16.87 - $20.3 $1,029 - $1,238	-61 Reduced 9.61%	574 $9,000
Q4 2017 Feb 15, 2018	BUY	$16.75 - $20.8 $10,636 - $13,208	635	635 $12,000

Others Institutions Holding HALO

# of Institutions

578

Shares Held

122M

Call Options Held

308K

Put Options Held

186K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.95B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Halozyme Therapeutics, Inc. Transaction History